Jennifer Champoux insider trades

Open-market stock purchases and sales by Jennifer Champoux, Chief Operating Officer at Monte Rosa Therapeutics, Inc, from SEC Form 4 filings since Jun 3, 2024.

Recent trades

DateStockTradeValue
Jun 23, 2026GLUE Monte Rosa Therapeutics, IncSold$43.5K
Jun 23, 2026GLUE Monte Rosa Therapeutics, IncBought (not open market)—
Jun 17, 2026GLUE Monte Rosa Therapeutics, IncSold$41.3K
Jun 17, 2026GLUE Monte Rosa Therapeutics, IncBought (not open market)—
May 27, 2026GLUE Monte Rosa Therapeutics, IncSold$43.5K
May 27, 2026GLUE Monte Rosa Therapeutics, IncBought (not open market)—
May 22, 2026GLUE Monte Rosa Therapeutics, IncSold$41.3K
May 22, 2026GLUE Monte Rosa Therapeutics, IncBought (not open market)—
Jan 5, 2026GLUE Monte Rosa Therapeutics, IncSold$39.9K
Jan 2, 2026GLUE Monte Rosa Therapeutics, IncBought (not open market)—
Jan 2, 2026GLUE Monte Rosa Therapeutics, IncBought (not open market)—

Companies traded

  • GLUE Monte Rosa Therapeutics, Inc: 5 sales, last Jun 23, 2026

Get free alerts when Jennifer Champoux files a new trade →